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Background
Multi-drug resistant (MDR) Acinetobacter baumannii is
an important cause of hospital acquired infection and
often increases mortality and length of stay[1-3]. The
mechanisms of resistance include: (1) antimicrobial-
inactivating enzymes such as -lactamases, (2) altera-
tion of membrane porin channels, and (3) mutations
that change cellular functions [4]. Accurate genotyping
and correlation to antimicrobial susceptibility will help
prevent and treat outbreaks of Acinetobacter.
The genome of A. baumannii ranges from 3.2 Mega-
bases (Mb) in the drug sensitive SDF strain up to 3.9
Mb in the MDR AYE strain. A surprisingly high propor-
tion of baumannii ORFs, (15%-20%), are located in
resistance islands or “alien islands” - long stretches of
DNA acquired from a foreign source. The MDR AYE
strain has an 86Kb island containing 45-50 drug resis-
tance genes located in an insertion hotspot [5]. Our
study aims to sequence several A. baumanniii s o l a t e s
from Metro Nashville General (NGH) Hospital and con-
duct a strain-to-reference genomic characterization of
clinical virulence factors.
Materials and methods
A retrospective review of the NGH hospital epidemiol-
o g yd a t ab a s ei n c l u d e d2 4 7i s o l a t e so fA. baumannii
from 164 patients (submitted, BMC Infectious Disease).
Cluster Software version 2.11 and TreeView software
grouped resistance phenotypes into six categories (see
Figure 1) [6].
1.Pan resistant
2.Pan sensitive
3.Sensitive to meropenem /imipenem only.
4.Sensitive to meropenem/imipenem and aminoglyco-
side only.
5.Sensitive to cephalosporins only.
6.Resistant to aminoglycosides only.
We chose a meripenum/imepenum and aminoglyco-
sides sensitive baumanii isolate for strain-to-reference
sequencing on an Illumina Genome Analyzer II system
a tt h eV a n d e r b i l tU n i v e r s i t yG e n o m eT e c h n o l o g yC o r e
(https://gtc.vanderbilt.edu/gtc/tech).
Conclusion
Initial sequencing yielded 5,250,420 reads of 43bp each,
yielding 225.76 Mb of total sequence. The reads from
our isolate were aligned to MDR baumannii reference
strain ACICU (NC_010611.1). Alignment was done with
the Bowtie Aligner [7]. Of the 5.2 million total reads,
4,004,012 (76.26%) aligned to AICIU, with a mean cov-
erage depth of 43.96 fold. Roughly 58% of the ACICU
genome was covered by at least one read. We will next
align the reads further with other baumannii reference
strains including MDR AYE (NC_010410) and non-
resistant strain SDF (NC_010400) in order to further
characterize and annotate our isolate at the genomic
level.
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Figure 1 Clustered baumannii groups. Left Side: full clustergram of all isolate phenotypes. Right Side: zoom in of resistance group 4:
meripenem/imipenum and aminoglycoside sensitive. Legend: red = resistant, green = sensitive, yellow = intermediate, black/gray = no data.
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